Multitargeted Modulation of Skin Dullness by HNHT Formulation: Synergistic Inhibition of Melanogenesis, Glycation, and Lipofuscin Deposition
Journal of Cosmetic Dermatology · 2026-05 · 25 (5)
DOI: 10.1111/jocd.70789 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 18.05.2026. Verfasst von Zheng Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Meyer Bio-Medicine Co., Ltd., Jinan, China. Hauptthemen laut MEDLINE: Melanogenesis, Skin Pigmentation, Lipofuscin. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Skin dullness, characterized by pigmentation disorders and yellowing, is a major cosmetic concern in Asian populations. Lipofuscin exhibits ultraviolet (UV)/visible light spectral absorption, reduces skin reflectance, and contributes to dullness, whereas existing therapies targeting melanogenesis and glycation lack comprehensive efficacy. This study aimed to evaluate the multimodal anti‐dullness effects of a novel formulation (HNHT: hyaluronic acid, niacinamide, hydrolyzed red algae, and tranexamic acid).
Methods
In vitro models (melanocytes, keratinocytes, fibroblasts, ex vivo skin model, and three‐dimensional (3D) skin models) were used to assess melanin regulation, glycation inhibition, and lipofuscin clearance.
Results
In ultraviolet B (UVB)‐exposed 3D skin models, 12.5% HNHT significantly improved skin color, appearance, and brightness (8.44% increase in L * value) and reduced melanin content (12.5% inhibition). Then, 12.5% HNHT downregulated the expression of key melanogenic genes ( TYR and MITF ; p < 0.001) in melanocytes and decreased UVB‐induced α‐melanocyte‐stimulating hormone secretion in keratinocytes (2867.78 versus 3444.72 pg/mL; p < 0.05). The formulation enhanced melanosome clearance through autophagy activation (174% LC3‐II increase, 80% GP100 reduction; p < 0.01) and boosted antioxidant capacity via Nrf2 activation and reactive oxygen species reduction ( p < 0.05). In glycation, 50% HNHT upregulated anti‐glycation enzymes ( GLO1 , GLO2 , and GPX1 ) and reduced carboxymethyllysine (CML) by 23.16% in fibroblasts ( p < 0.01), while 100% HNHT decreased CML by 34.93% in ex vivo skin model. Furthermore, 50% HNHT suppressed hydrogen peroxide‐induced lipofuscin accumulation by 52.20% ( p < 0.01).
Conclusions
These findings highlight HNHT as a multitargeted therapeutic agent that alleviates skin dullness through melanogenesis inhibition, enhances melanosome degradation, suppresses glycation, mitigates oxidative stress, and promotes lipofuscin clearance, thereby establishing a novel therapeutic paradigm against solar radiation‐induced hyperpigmentation and skin yellowing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Meyer Bio-Medicine Co., Ltd., Jinan, China.
- Shandong Meimao Pharmaceutical Co., Ltd., Jinan, China.
- National Glycoengineering Research Center, Shandong University, Jinan, China.
ORCID-Profile: Zheng Wang, Yumei Fan
Zitieren
APA
Wang, Z., Fan, Y., & Ling, P. (2026). Multitargeted Modulation of Skin Dullness by HNHT Formulation: Synergistic Inhibition of Melanogenesis, Glycation, and Lipofuscin Deposition. Journal of Cosmetic Dermatology, 25(5). https://doi.org/10.1111/jocd.70789
Vancouver
Wang Z, Fan Y, Ling P. Multitargeted Modulation of Skin Dullness by HNHT Formulation: Synergistic Inhibition of Melanogenesis, Glycation, and Lipofuscin Deposition. Journal of Cosmetic Dermatology. 2026;25(5). doi:10.1111/jocd.70789
BibTeX
@article{Wang2026,
author = {Wang, Zheng and Fan, Yumei and Ling, Peixue},
title = {Multitargeted Modulation of Skin Dullness by HNHT Formulation: Synergistic Inhibition of Melanogenesis, Glycation, and Lipofuscin Deposition},
journal = {Journal of Cosmetic Dermatology},
year = {2026},
volume = {25},
number = {5},
doi = {10.1111/jocd.70789}
}
EUVIMED